1,260,930 Shares in GoodRx Holdings, Inc. (NASDAQ:GDRX) Acquired by Clearbridge Investments LLC

Clearbridge Investments LLC acquired a new position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 1,260,930 shares of the company's stock, valued at approximately $5,863,000. Clearbridge Investments LLC owned 0.33% of GoodRx at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in GDRX. Versor Investments LP bought a new stake in shares of GoodRx during the 4th quarter worth approximately $54,000. Verus Capital Partners LLC acquired a new position in GoodRx during the fourth quarter valued at approximately $55,000. Steward Partners Investment Advisory LLC bought a new stake in GoodRx during the fourth quarter worth $56,000. EntryPoint Capital LLC acquired a new stake in shares of GoodRx in the 4th quarter valued at $56,000. Finally, Aigen Investment Management LP bought a new position in shares of GoodRx in the 4th quarter valued at $62,000. 63.77% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on GDRX. Morgan Stanley dropped their price objective on GoodRx from $7.00 to $6.00 and set an "equal weight" rating for the company in a research report on Tuesday, December 17th. Citigroup reduced their price target on shares of GoodRx from $7.00 to $6.25 and set a "buy" rating on the stock in a research note on Friday, January 10th. KeyCorp lowered their price objective on shares of GoodRx from $7.00 to $6.00 and set an "overweight" rating for the company in a research report on Wednesday, January 8th. Finally, Wells Fargo & Company cut their target price on shares of GoodRx from $9.00 to $8.00 and set an "overweight" rating on the stock in a research report on Friday, February 28th. Three equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $8.18.

Remove Ads

GoodRx Trading Up 5.9 %

Shares of NASDAQ:GDRX traded up $0.24 during mid-day trading on Tuesday, reaching $4.25. 527,891 shares of the company's stock were exchanged, compared to its average volume of 1,369,072. The company has a debt-to-equity ratio of 0.70, a quick ratio of 5.48 and a current ratio of 5.48. GoodRx Holdings, Inc. has a twelve month low of $3.82 and a twelve month high of $9.26. The firm has a market capitalization of $1.63 billion, a price-to-earnings ratio of -141.83, a PEG ratio of 2.46 and a beta of 1.25. The business's fifty day moving average price is $4.71 and its 200-day moving average price is $5.14.

GoodRx Company Profile

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.